The RKI restructure into two silos—Infectious Diseases vs. Non-Communicable Diseases—is a strategic decoupling of causality. BIPAM By administratively separating pathogens from the neurological/vascular "lifestyle" diseases they cause (Dementia, Diabetes, Depression), the state creates a legal vacuum for accountability. BIPAM This "Silo Logic" serves a predatory market: Companies like CGM and investors like BlackRock profit from managing permanent erosion rather than curing its root. BIPAM When neurotropic damage (e.g., SARS-CoV-2/Neuro-Covid) is rebranded as "Ageing" or "Mental Health," the pathological network turns a biological catastrophe into a perpetual revenue stream. BIPAM The result is Institutional Dementia. As decision-makers (WEF, Governments) suffer cumulative executive dysfunction from repeat infections, they become biologically incapable of long-term risk assessment. BIPAM They enforce digital total control (Palantir) to replace the failing human judgment of an eroded society. BIPAM By separating pathogenesis (the biological cause through infections) from prevention (the management of chronic consequences), the RKI creates ideal points of entry for the private sector. BlackRock holds massive stakes in companies that profit from lifelong medication for "non-communicable" diseases through ETFs such as the iShares Global Healthcare ETF (IXJ) or the iShares US Pharmaceuticals ETF (IHE) BIPAM Lilly (LLY): A heavyweight in almost all BlackRock health portfolios (approximately 9–10% weighting) Johnson & Johnson (JNJ) & AbbVie (ABBV): These companies dominate the indices for chronic inflammation and neurological therapies Merck KGaA: BlackRock increased its voting rights in this German pharmaceutical giant to over 7.2% in March 2026. 🤑 CompuGroup Medical (CGM): While the founding Gotthardt family holds the majority stake (approx. 50%), the company, following its delisting in June 2025, is closely linked to the private equity giant CVC Capital Partners (approx. 27.8%). BlackRock often operates behind the scenes through institutional inflows or as an indirect investor in the participating funds... UnitedHealth Group (UNH): One of the largest data managers in the healthcare sector, regularly appearing as a top holding in BlackRock funds such as the iShares S&P 500 Health Care Sector UCITS ETF. The shift away from addressing the root causes (infection control) towards the profitable management of erosion. The BIPAM department provides the data that BlackRock-funded companies need to keep citizens in a cycle of constant diagnosis and treatment. According to McKinsey guidelines, the restructuring of the Robert Koch Institute (RKI) and the establishment of the Federal Institute for Prevention and Education in Medicine (BIPAM) follow a business logic that instrumentalizes prevention as an efficiency lever to increase GDP and reduce costs. Concepts such as the E-Health Monitor 2025 primarily position BIPAM as a tool for monetizing health data and increasing workforce through "silo management", while infectious disease causalities are administratively separated (McKinsey E-Health Monitor 2025). McKinsey's strategies for the new BIPAM department aim to define health not as the absence of disease, but as a "manageable state". The logic: A cured person is economically dead. A chronically ill person (with "non-communicable" dementia or depression) is a lifelong subscription. The implementation: The separation of the RKI departments ensures that the cause (the neurotropic virus) disappears from focus. What remains is a patient who is constantly "optimized" and medicated via digital monitoring interfaces (CGM). McKinsey papers celebrate the telematics infrastructure #TI as an "enabler." The key point: By recording every blood test result and every prescription in real time, the individual becomes completely controllable. McKinsey recommends that the government outsource "prevention" to private actors. The consequence: The government (RKI/BIPAM) provides the legitimacy and the data, while corporations like Palantir supply the analysis software to identify "high-risk groups". It is lucrative because biology (the pathogen) creates the demand for drugs, while politics (the splitting of the RKI) obscures the causality and IT (CGM/BlackRock) secures the profit. McKinsey: “Optimizing the patient journey” In the reports on the “transformation of the healthcare system” (often the basis for the RKI reform and the Charité restructuring), a patient is no longer defined as a subject to be healed, but as an “asset in the continuous care cycle”. The logic: The administrative separation at the RKI (infection vs. chronic disease) ensures that pathogenesis (the cause) never burdens the prevention budget (the administration). The gradual merging of the electronic health record (ePA) with a de facto social credit score based on the Palantir analytics model, implemented by German institutions. By shifting the telematics infrastructure (TI) into the control of corporations like CGM and the administrative splitting of the RKI (separation of infection and chronic consequences), the health record becomes the ultimate surveillance instrument: The data depth: Not only are diagnoses recorded, but behavioral patterns are derived through AI analysis (Palantir Foundry). Who shows signs of neurotropism or executive dysfunction? The algorithmic prognosis: The system detects biological erosion (e.g., incipient depression as in Grupp) before the individual can react. In Germany, an open points system like the one in China will not be introduced, but rather an economic selection process through back channels: Risk profiling: Palantir software enables the matching of health data with financial flows (BlackRock holdings) and social movements. Gematik and the new BIPAM department act as interfaces. They legitimize the flow of data to industry (pharmaceuticals/IT) as "prevention". Because the researchers and officials are often themselves limited in their executive capacity due to multiple infections, they can no longer recognize the totalitarianism of this system as such. The Administrative Silo (The RKI Lie): The division of the RKI into infectious and non-communicable diseases (BIPAM) is a deliberate separation of causality. Biological damage (dementia, depression, vascular diseases) is administratively decoupled from its infectious cause in order to absolve the state and industry of liability. The Economic Silo (BlackRock & McKinsey): Investors like BlackRock and consultants like McKinsey control the "management of decay." A cured person is worthless; a chronically ill person (erosion patient) is a lifelong revenue stream.